Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Papillomavirus Infections 2Breast Neoplasms 2Acquired Immunodeficiency Syndrome 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Ovarian Cysts 1Neoplasms 1Menorrhagia 1Leiomyoma 1High-grade Anal Intraepithelial Neoplasia 1HIV Infections 1Endometriosis 1Benign Ovarian Tumor 1Anus Neoplasms 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Electrocoagulation × Clear all
NCT07050329 2025-07-03

Comparison of Operation Time, Drain Duration, and Seroma Formation After Modified Radical Mastectomy Using Ultrasonic Dissector Versus Electrocautery in Women With Breast Cancer

Quaid-e-Azam Medical College

Phase NA Completed
138 enrolled
Breast

Breast Neoplasms

NCT01587248 2012-04-30

HMRM

Aga Khan University

Phase 3 Completed
152 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡